A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses and to Evaluate the Food Effect of TollB-001
Latest Information Update: 02 Nov 2023
At a glance
- Drugs TollB-001 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Beijing Toll Biotech
Most Recent Events
- 02 Nov 2023 New trial record